Health & Biotech
Check out the latest Cannabis Stocks news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
News
Weed Week: California legalises hemp and Aussie medicinal cannabis use hits all-time high
Health & Biotech
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops
News
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025
News
Pot stock Little Green Pharma flags plans to expand from cannabis to psychedelic medicines
Health & Biotech
ASX Pot Stocks: Roto-Gro jumps on Canniberia’s pre-approval for cannabis cultivation
News
Weed Week: Cannabis trade shows and Europe imports medicinal marijuana
Health & Biotech
Why haven’t any ASX pot stocks got CBD on Australian pharmacy shelves yet? And when will we see them?
Mining
ASX Pot Stocks: BOD Australia jumps 12% on record $7.52 million revenue for FY21
Guides
ASX Cannabis Stocks Guide 2021: Here’s everything you need to know
News
Pot Stocks: Emyria and Cann split, but who will win the race to register their CBD product first?
News
Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025
News
Weed Week: Cannabis business degrees, cornering Germany’s €200M market and Hanks Kerchiefs hits stores
Stockhead TV
Q-Wrapz: Oriel Morrison interviews Roby Zomer, Managing Director of MGC Pharma (ASX:MXC)
Health & Biotech
Cymra secures cultivation permit as it builds a first-mover advantage in cannabis genetics
Health & Biotech
Medibis raises funds for research and cultivation facility, sets eyes on huge medicinal cannabis market
Health & Biotech
Creso Pharma welcomes Senate Democrats’ bid to legalise cannabis
Health & Biotech
Weed Week: The CanCoin, cannabis tourism, and record medicinal product sales in Australia
Health & Biotech
Creso Pharma completes acquisition of Canada-based Halucenex, set to enter the US$100 billion psychedelic market
Health & Biotech
Creso Pharma expands global footprint to Netherlands with maiden sale of Red Light Holland
Health & Biotech
Cannabis stocks celebrate Pershing ownership change
Health & Biotech
Creso Pharma delivers another strong quarter as Connecticut brings a new market opportunity
Health & Biotech
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry
Health & Biotech
Creso Pharma is Canada-bound after announcing a merger with Red Light Holland
Health & Biotech
Creso Pharma US shares surge on dual-listing
Health & Biotech
Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets
Health & Biotech
Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market
Health & Biotech
Creso Pharma about to enter California market after major legislation shift on psychedelics
Health & Biotech
Creso Pharma expands into Eastern Europe with animal product launch in Poland
Health & Biotech
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months
Health & Biotech
ECS Botanics’ new subsidiary extends supply agreement for its sun-kissed cannabis flower
Health & Biotech
Here’s why cannabis M&A activity is on the rise and only just getting started in Australia
Health & Biotech
Elixinol the latest pot stock to M&A; recruits German media entrepreneur to its board
Food & Agriculture
ASX cannabis stock Primary Hemp’s plant-based milk will be sold in Coles
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
News
Winners Column: Here are the top 50 ASX small cap stocks for December
Health & Biotech
ECS Botanics poised to benefit from shift to ‘cannabis phase two’
Health & Biotech
Check Up: Joining ‘observational study’ sends Avecho shares soaring
News
Weed Week: More cannabis reform in the works as pot stocks cool off
Health & Biotech
Cannabis stocks are finishing 2020 on a high; Cann Group, Bod announce new European orders
Health & Biotech
Creso Pharma receives first pet-health cannabis orders in Latin America
Health & Biotech
MGC Pharmaceuticals confirms Phase II trial success for anti-inflammatory COVID treatment
News
Stonkhead: Will weed stocks end the year on a high note?
News
Cannabis stocks take a well-earned breather after days of strong gains
Health & Biotech
ASX pot stocks keep climbing after US House vote; now up 52 per cent in a month
Health & Biotech
What cannabis investors need to know ahead of the TGA’s decision
Stockhead TV
Why Australia’s medicinal cannabis has the leading edge
Health & Biotech
StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed
Load More
